(Q44101945)

29 November 2017

title

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model (English)

1 reference

29 November 2017

6

H Holte

1 reference

29 November 2017

A Hollender

1

1 reference

29 November 2017

S Kvaloy

2

1 reference

29 November 2017

O Nome

3

1 reference

29 November 2017

E Skovlund

4

1 reference

29 November 2017

K Lote

5

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

13

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

1099-1107

1 reference

Involvement of the central nervous system by non-Hodgkin's lymphoma: the Southwest Oncology Group experience

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of aggressive histologic type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Non-Hodgkin's lymphoma involving the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

CNS involvement in mantle-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Risk Factors for Central Nervous System Involvement in Non-Hodgkins-Lymphoma a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF175

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDF175

1 reference

29 November 2017

1 reference